Northwestern Mutual Wealth Management’s Travere Therapeutics TVTX Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-204	Closed	-$3.02K	–	4052
2025 Q2	$3.02K	Hold	204	–	–	﹤0.01%	3152
2025 Q1	$3.66K	Hold	204	–	–	﹤0.01%	3020
2024 Q4	$3.55K	Buy	+204	New	+$3.61K	﹤0.01%	3044
2024 Q2	–	Sell	-39	Closed	-$301	–	3827
2024 Q1	$301	Buy	+39	New	+$329	﹤0.01%	3360
2023 Q3	–	Sell	-45	Closed	-$691	–	3536
2023 Q2	$691	Buy	+45	New	+$819	﹤0.01%	3136
2017 Q1	–	Sell	-26	Closed	–	–	2401
2016 Q4	$0	Buy	+26	New	+$532	﹤0.01%	2382

Other funds holding TVTX

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Northwestern Mutual Wealth Management's TVTX Position: Q3 2025 in Review

Northwestern Mutual Wealth Management sold out of Travere Therapeutics (TVTX) in Q3 2025, closing a stake of 204 shares — an estimated $3.02K sold.

Northwestern Mutual Wealth Management first reported a position in TVTX in Q4 2016 and held it in 6 quarters. The position peaked at $3.66K in Q1 2025. 238 funds tracked by Wall St. Rank hold TVTX as of Q3 2025.

Northwestern Mutual Wealth Management reported no remaining Travere Therapeutics position as of Q3 2025 after selling out during the quarter.
Northwestern Mutual Wealth Management sold 204 Travere Therapeutics shares in Q3 2025, an estimated $3.02K.
Northwestern Mutual Wealth Management first reported a position in Travere Therapeutics in Q4 2016 and held it in 6 quarters.
Northwestern Mutual Wealth Management's Travere Therapeutics position peaked at $3.66K in Q1 2025.
238 funds tracked by Wall St. Rank held Travere Therapeutics as of Q3 2025.

Based on Northwestern Mutual Wealth Management's 13F filing for Q3 2025, filed 14 Nov 2025.